Serena Williams, who was once celebrated for her curves, has confirmed that the reason for her newly trim figure is the use ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.

This is all you need to know about the new weight loss jab 'Reta' that's said to be 3 times stronger than Ozempic.

Serena Williams recently detailed her weight loss journey, sharing that she lost 31 pounds with the assistance of a GLP-1 ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Serena Williams has just publicly admitted to using GLP-1 medication for weight loss. The 23-time Grand Slam champion says ...

On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Wegovy has become a ...

COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that ...

Three new studies presented at the Society of NeuroInterventional Surgery’s 22nd Annual Meeting suggest that medications like ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...

Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the Israeli military’s use of its technology during the ongoing war in Gaza. A second ...